in clinical trials co-ordinated in italy by glaxo s.p.a. from may 1984 to february 1988 , 553 patients aged over 65 years ( 376 men and 177 women ) , suffering from different infectious diseases ( mostly lrti and uti ) , were treated with ofloxacin , a new broad-spectrum quinolone .
C0042029
uti
C0028902
ofloxacin